nav-left cat-right
cat-right

5th annual ADC Summit London on May 23-24, 2016

SMi’s 5th annual ADC Summit provides a comprehensive analysis of the various approaches with the next generation ADCs. Hear the latest insights from Takeda on Adcetris; discuss the latest advancements in research and development from Medimmune; and analyse case studies from big pharma companies such as Roche, Bayer, Pfizer, AstraZeneca, Novartis and many more. Join industry experts as they share, confer and debate how...

3rd Allergy, Asthma, & COPD Conference Januar...

GTCbio is delighted to present the 3rd Allergy, Asthma, & COPD Conference, to be held on January 25-26, 2016 in San Diego, CA. The conference will bring together industry, academia and government experts in the field of allergy, asthma and COPD. Experts will facilitate discourse on the challenges and opportunities for therapeutic and drug development for allergic diseases for the current and future generations. Topics...

6th Ubiquitin Research & Drug Discovery Confe...

We are pleased to invite you to GTCbio’s 6th Ubiquitin Research & Drug Discovery Conference, which will take place February 29 – March 1, 2016 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with...

Cancer Diagnostics Conference November 16-17, 2015...

We invite you to attend the Cancer Diagnostics Conference, which will take place November 16-17, 2015 in San Francisco, CA. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss new research in cancer diagnostics, including next generation sequencing, the use of clinical utility of cell-free...

World AntiMicrobial Resistance Congress USA 2015 O...

The World AntiMicrobial Resistance Congress USA gathers key stakeholders from government, funding agencies, pharma, academia and payers to discuss the urgent need for new antibiotics. President Obama has outlined his 5-year action plan to fight AMR and is seeking to double the AMR funding to $1.2B, but the bigger challenge is how to deliver these actions. This 2-day conference presents solutions through key notes, case study...

3rd Antibody & Protein Therapeutics Conferenc...

We welcome you to the 3rd Antibody & Protein Therapeutics Conference, which will be held October 22-23, 2015 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development. Representatives from big pharma, academic institutions...
Page 2 of 3412345...102030...Last »